Synthesis, Characterization, HSA/DNA Binding, and Cytotoxic Activity of [RuCl2(η6-p-cymene)(bph-κN)] Complex
Molecules · 2025
DOI: 10.3390/molecules30153088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Stefan Perendija und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Physical Chemistry, University of Belgrade, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: DNA, Coordination Complexes, Serum Albumin, Human, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Academic Exchange Service, Ministry of Science, Technological Development and Innovation of the Republic of Serbia, DAAD HAW EURABridge project.
Abstract (Originalsprache)
A novel ruthenium(II) complex, [RuCl2(η6-p-cymene)(bph-κN)] (1), was synthesized and structurally characterized using FTIR and NMR spectroscopy. Density functional theory (DFT) calculations supported the proposed geometry and allowed for comparative analysis of experimental and theoretical spectroscopic data. The interaction of complex 1 with human serum albumin (HSA) and calf thymus DNA was investigated through fluorescence quenching experiments, revealing spontaneous binding driven primarily by hydrophobic interactions. The thermodynamic parameters indicated mixed quenching mechanisms in both protein and DNA systems. Ethidium bromide displacement assays and molecular docking simulations confirmed DNA intercalation as the dominant binding mode, with a Gibbs free binding energy of −34.1 kJ mol−1. Antioxidant activity, assessed by EPR spectroscopy, demonstrated effective scavenging of hydroxyl and ascorbyl radicals. In vitro cytotoxicity assays against A375, MDA-MB-231, MIA PaCa-2, and SW480 cancer cell lines revealed selective activity, with pancreatic and colorectal cells showing the highest sensitivity. QTAIM analysis provided insight into metal–ligand bonding characteristics and intramolecular stabilization. These findings highlight the potential of 1 as a promising candidate for further development as an anticancer agent, particularly against multidrug-resistant tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Physical Chemistry, University of Belgrade, 11000 Belgrade, Serbia.
- Department of Engineering and Natural Sciences, University of Applied Sciences Merseburg, D-06217 Merseburg, Germany.
- Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, 00185 Rome, Italy.
- Institute for Medical Research, University of Belgrade, 11000 Belgrade, Serbia.
ORCID-Profile: Stefan Perendija, Dušan Dimić, Thomas Eichhorn, Aleksandra Rakić, Luciano Saso, Đura Nakarada, Teodora Dragojević, Jasmina Dimitrić Marković, Goran N Kaluđerović
Förderung
- German Academic Exchange Service
- Ministry of Science, Technological Development and Innovation of the Republic of Serbia
- DAAD HAW EURABridge project
Zitieren
APA
Perendija, S., Dimić, D., Eichhorn, T., Rakić, A., Saso, L., Nakarada, Đ., Đikić, D., Dragojević, T., Dimitrić Marković, J., & Kaluđerović, G. N. (2025). Synthesis, Characterization, HSA/DNA Binding, and Cytotoxic Activity of [RuCl2(η6-p-cymene)(bph-κN)] Complex. Molecules. https://doi.org/10.3390/molecules30153088
Vancouver
Perendija S, Dimić D, Eichhorn T, Rakić A, Saso L, Nakarada Đ, et al. Synthesis, Characterization, HSA/DNA Binding, and Cytotoxic Activity of [RuCl2(η6-p-cymene)(bph-κN)] Complex. Molecules. 2025. doi:10.3390/molecules30153088
BibTeX
@article{Perendija2025,
author = {Perendija, Stefan and Dimić, Dušan and Eichhorn, Thomas and Rakić, Aleksandra and Saso, Luciano and Nakarada, Đura and Đikić, Dragoslava and Dragojević, Teodora and Dimitrić Marković, Jasmina and Kaluđerović, Goran N},
title = {Synthesis, Characterization, HSA/DNA Binding, and Cytotoxic Activity of [RuCl2(η6-p-cymene)(bph-κN)] Complex},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30153088}
}
EUVIMED